Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3456

Cell-based Assay Market by Product (Consumable, Instrument, Service, and Software), Application (Drug Discovery; Basic Research; Absorption, Distribution, Metabolism, & Excretion (ADME) Studies; Predictive Toxicology; and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, Contract Research Organizations, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_174425
Pages: 260
Sep 2017 | 1572 Views
face gplus_n
Author's : Onkar Sumant, Sohail Shaikh
Tables: 64
Charts: 57
twit_n pr_n

Cell-based Assay Market Overview:

Cell-based Assay Market was valued at $3,625 million in 2016, and is expected to reach $10,618 million in 2023, registering a CAGR of 16.5% from 2017 to 2023. Cell-based assays encompass a variety of assays that measure cellular parameters such as cell toxicity, proliferation, production of markers, activation of specific signaling pathways, motility, and changes in morphology.

These assays rely on reporter gene assays, which have high sensitivity owing to signal amplification of cell-signaling cascades, and thus are ideal for miniaturization. Cell-based assays are widely applied in high-throughput screening (HTS) formats.

The demand for cell-based assay has increased significantly over the past few years, owing to surge in cell-based applications in drug discovery and rise in technological advancements in cell-based assays methodologies. In addition, adoption of high-throughput screening methods and increase in R&D investment further drive the market growth. However, high costs associated with these assays and lack of skilled professionals hamper this growth. Furthermore, surge in adoption of label-free cell-based assays and untapped potential in developing countries offer significant opportunities to the market players.

Global Cell-based Assay Market Segmentation

GLOBAL CELL-BASED ASSAY MARKET SEGMENTATION

Get more information on this report : Request Sample Pages

The cell-based assay market is segmented based on product, application, end user, and geography. Based on product, it is categorized into consumable, instrument, service, and software. The consumable segment includes reagents, microplates, probes & labels, assay kits, cell lines, and others.

Assay kits are further sub-divided into reporter gene assays, cell growth assays, second messenger assays, cell death assays, and others. Likewise, the cell lines are divided into immortalized cell lines, primary cell lines, and stem cell lines. Based on application, the market is divided into drug discovery; basic research; absorption, distribution, metabolism, & excretion (ADME) studies; predictive toxicology; and others.

On the basis of end user, it is categorized into pharmaceutical & biotechnology companies, academic & government research institutes, contract research organizations, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Cell-based Assay Market, by Geography, 2016-2023 ($MILLION)

CELL-BASED ASSAY MARKET, BY GEOGRAPHY, 20162023 ($MILLION)

Get more information on this report : Request Sample Pages

North America generated the highest revenue in the global cell-based assay market in 2016. However, Asia-Pacific possesses market potential for growth of cell-based assays, owing to increase in awareness about these assays for drug discovery, rise in cell-based assay applications, and others. This region is anticipated to experience fast-paced growth, in terms of development and use of cell-based assays.

The consumables hold a significant share in the global cell-based assay market. This trend is expected to continue during the forecast period.

Global Cell-based Assay Market, by Product 2016 (%)

GLOBAL CELL-BASED ASSAY MARKET, BY PRODUCT 2016 (%)

Get more information on this report : Request Sample Pages

The key players operating in the global cell-based assay market are Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Lonza Group Ltd., Cell Signaling Technology, Inc., and Promega Corporation

The other prominent players in the value chain include Macrogen, Inc., New England Biolabs, Inc., Cisbio Bioassays, Cell Biolabs, Inc., and DiscoverX Corporation

Key Benefits

  • The study provides an in-depth analysis of the global cell-based assay market, with current trends and future estimations to elucidate the imminent investment pockets.
  • A quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities is discussed.
  • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
  • Porters Five Forces model interprets the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

Cell-based Assay Market Key Segments:

By Product

  • Consumable
    • Reagents
    • Microplates
    • Probes & Labels
    • Assay Kits
      • Reporter Gene Assays
      • Cell Growth Assays
      • Second Messenger Assays
      • Cell Death Assays
      • Others
    • Cell Lines
      • Immortalized Cell Lines
      • Primary Cell Lines
      • Stem Cell Lines
    • Other Consumables
  • Instrument
  • Service
  • Software

By Application

  • Drug Discovery
  • Basic Research
  • ADME Studies
  • Predictive Toxicology
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PATENTS ANALYSIS

3.3.1. Patent analysis by year
3.3.2. Patent analysis by region

3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET SHARE ANALYSIS

3.5.1. Cell-based assay market share (2012-2017)

3.6. MARKET DYNAMICS

3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities

Chapter: 4 GLOBAL CELL-BASED ASSAY MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. CONSUMABLES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. Reagents

4.2.4.1. Market size & forecast

4.2.5. Microplates

4.2.5.1. Market size and forecast

4.2.6. Probes & Labels

4.2.6.1. Market size & forecast

4.2.7. Assay Kits

4.2.7.1. Market size & forecast

4.2.8. Cell Lines

4.2.8.1. Market size & forecast

4.2.9. Other Consumables

4.2.9.1. Market size & forecast

4.3. INSTRUMENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast

4.4. SOFTWARE

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast

4.5. SERVICES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size & forecast

Chapter: 5 GLOBAL CELL-BASED ASSAY MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. DRUG DISCOVERY

5.2.1. Market size & forecast

5.3. BASIC RESEARCH

5.3.1. Market size & forecast

5.4. ADME STUDIES

5.4.1. Market size & forecast

5.5. PREDICTIVE TOXICOLOGY

5.5.1. Market size & forecast

5.6. OTHER APPLICATIONS

5.6.1. Market size & forecast

Chapter: 6 GLOBAL CELL-BASED ASSAY MARKET, BY END USERS

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. PHARMACEUTICAL COMPANIES

6.2.1. Market size & forecast

6.3. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES

6.3.1. Market size & forecast

6.4. BIOTECHNOLOGY COMPANIES

6.4.1. Market size & forecast

6.5. OTHER END USERS

6.5.1. Market size & forecast

Chapter: 7 GLOBAL CELL-BASED ASSAY MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size & forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size & forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size & forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size & forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size & forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

Chapter: 8 COMPANY PROFILES

8.1. BECTON DICKINSON AND COMPANY

8.1.1. Operating business segments
8.1.2. Business performance

8.2. THERMO FISHER SCIENTIFIC, INC

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. DANAHER CORPORATION,

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. GENERAL ELECTRIC COMPANY

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. MERCK KGAA

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. PERKINELMER, INC

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. BIO-RAD LABORATORIES, INC.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. LONZA GROUP LTD

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. CELL SIGNALING TECHNOLOGY, INC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. PROMEGA CORPORATION

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. GLOBAL CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. CELL-BASED ASSAY CONSUMABLES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. CELL-BASED ASSAY MARKET FOR REAGENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. CELL-BASED ASSAY MARKET FOR MICROPLATES, BY REGION, 2016-2023 ($MILLION)
TABLE 6. CELL-BASED ASSAY MARKET FOR PROBES AND LABELS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 8. CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 10. CELL-BASED ASSAY MARKET FOR CELL LINES, BY REGION, 2016-2023 ($MILLION)
TABLE 11. CELL-BASED ASSAY MARKET FOR OTHER CONSUMABLES, BY REGION, 2016-2023 ($MILLION)
TABLE 12. CELL-BASED ASSAY INSTRUMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 13. CELL-BASED ASSAY SOFTWARE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. CELL-BASED ASSAY SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 16. DRUG DISCOVERY CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. BASIC RESEARCH CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. ADME STUDIES CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. PREDICTIVE TOXICOLOGY CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. OTHER APPLICATIONS CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL CELL-BASED ASSAY MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 22. PHARMACEUTICAL COMPANIES CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. BIOTECHNOLOGY COMPANIES CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 25. OTHER END-USERS CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 27. NORTH AMERICA CELL-BASED ASSAY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERICA CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA CELL-BASED ASSAY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 34. EUROPE CELL-BASED ASSAY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. EUROPE CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 36. EUROPE CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 37. EUROPE CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 38. EUROPE CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 39. EUROPE CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 40. EUROPE CELL-BASED ASSAY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. ASIA-PACIFIC CELL-BASED ASSAY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 42. ASIA-PACIFIC CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 43. ASIA-PACIFIC CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC CELL-BASED ASSAY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 48. LAMEA CELL-BASED ASSAY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 49. LAMEA CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 50. LAMEA CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 51. LAMEA CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 52. LAMEA CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 53. LAMEA CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 54. LAMEA CELL-BASED ASSAY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 55. BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 56. THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
TABLE 57. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 58. GENERAL ELECTRIC COMPANY.: COMPANY SNAPSHOT
TABLE 59. MERCK KGAA: COMPANY SNAPSHOT
TABLE 60. PERKINELMER, INC: COMPANY SNAPSHOT
TABLE 61. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 62. LONZA GROUP LTD: COMPANY SNAPSHOT
TABLE 63. CELL SIGNALING TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 64. PROMEGA CORPORATION: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. TOP INVESTMENT POCKETS: GLOBAL CELL-BASED ASSAY MARKET, BY APPLICATION (2016)
FIGURE 2. TOP WINNING STRATEGIES: NATURE AND TYPE (2015-2017)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND COMPANY (2015-2017)
FIGURE 4. PATENT ANALYSIS BY REGION
FIGURE 5. BARGAINING POWER OF BUYERS
FIGURE 6. BARGAINING POWER OF SUPPLIERS
FIGURE 7. THREAT OF NEW ENTRANTS
FIGURE 8. THREAT OF SUBSTITUTION
FIGURE 9. COMPETITIVE RIVALRY
FIGURE 10. MARKET SHARE ANALYSIS (2016)
FIGURE 11. CELL-BASED ASSAYMARKET: PRODUCT SEGMENATION
FIGURE 12. U.S. CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 13. CANADA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 15. GERMANY CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 16. FRANCE CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 17. UK CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 18. ITALY CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 19. SPAIN CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 20. REST OF EUROPE CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 21. JAPAN CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 22. CHINA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 23. AUSTRALIA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 25. SOUTH KOREA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 26. TAIWAN CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 27. REST OF ASIA-PACIFIC CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 28. BRAZIL CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY CELL-BASED ASSAY MARKET, 2016-20223 ($MILLION)
FIGURE 30. SAUDI ARABIA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 31. REST OF LAMEA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 32. BECTON DICKINSON AND COMPANY: NET SALES, 2014-2017 ($MILLION)
FIGURE 33. BECTON DICKINSON AND COMPANY: REVENUE BY SEGMENT, 2015 (%)
FIGURE 34. THERMO FISHER SCIENTIFIC, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 35. THERMO FISHER SCIENTIFIC, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 36. THERMO FISHER SCIENTIFIC, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 37. DANAHER CORPORATION: NET SALES, 2014-2017 ($MILLION)
FIGURE 38. DANAHER CORPORATION: REVENUE BY SEGMENT, 2015 (%)
FIGURE 39. DANAHER CORPORATION: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 40. GENERAL ELECTRIC COMPANY.: NET SALES, 2014-2017 ($MILLION)
FIGURE 41. GENERAL ELECTRIC COMPANY.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 42. GENERAL ELECTRIC COMPANY.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 43. MERCK KGAA: NET SALES, 2014-2017 ($MILLION)
FIGURE 44. MERCK KGAA: REVENUE BY SEGMENT, 2015 (%)
FIGURE 45. MERCK KGAA: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 46. PERKINELMER, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 47. PERKINELMER, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 48. PERKINELMER, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 49. BIO-RAD LABORATORIES, INC.: NET SALES, 2014-2017 ($MILLION)
FIGURE 50. BIO-RAD LABORATORIES, INC.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 51. BIO-RAD LABORATORIES, INC.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 52. LONZA GROUP LTD: NET SALES, 2014-2017 ($MILLION)
FIGURE 53. LONZA GROUP LTD: REVENUE BY SEGMENT, 2015 (%)
FIGURE 54. LONZA GROUP LTD: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 55. PROMEGA CORPORATION: NET SALES, 2014-2017 ($MILLION)
FIGURE 56. PROMEGA CORPORATION: REVENUE BY SEGMENT, 2015 (%)
FIGURE 57. PROMEGA CORPORATION: REVENUE BY GEOGRAPHY, 2015 (%)

 

Cell-based assays are procedures that are exclusively designed to target specific cells using antibodies or other molecular moieties to understand the efficacy and functionality of drugs. Cell-based assay products have changed drastically over the past decade and continue to evolve in response to new technologies with respect to drug discovery.

Increase in demand to produce more drug candidates and decrease attrition during the drug development procedures has been witnessed. Recent advances in cell-based assay technology have increased due to need to maximize the efficiency and minimize the probability of errors, failure, and contamination associated with high-throughput cell culture.

In addition, the cell-based assay market is driven by the necessity to decrease development and operational costs associated with drug development. Cell-based assay screening holds high potential with respect to discovery of new drug targets and is anticipated to revolutionize the drug discovery industry during the forecast period. Rapid technological advances, increase in cell-based research activities, and rise in adoption of high-throughput screening methods in drug discovery are expected to supplement the market growth. Moreover, increase in availability of investments and funds in drug discovery is expected to boost the growth.

However, lack of skilled professionals who are proficient in performing cell-based assays and high costs associated with these assays may restrain the market growth. Furthermore, surge in adoption of label-free cell-based assays and untapped potential of developing economies are anticipated to offer lucrative opportunities to the key market players during the forecast period. The employment of technologically advanced cell-based assay products is highest in North America, owing to the increase in adoption of cell-based assay products and technologies, followed by Europe and Asia-Pacific.

 

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
Cell-based Assay Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo